sr 95531 has been researched along with orlistat in 2 studies
Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (orlistat) | Trials (orlistat) | Recent Studies (post-2010) (orlistat) |
---|---|---|---|---|---|
610 | 0 | 209 | 1,432 | 274 | 539 |
Protein | Taxonomy | sr 95531 (IC50) | orlistat (IC50) |
---|---|---|---|
Phosphatidylserine lipase ABHD16A | Homo sapiens (human) | 0.1 | |
Pancreatic triacylglycerol lipase | Sus scrofa (pig) | 0.4214 | |
Lipoprotein lipase | Homo sapiens (human) | 0.066 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.42 | |
Hepatic triacylglycerol lipase | Homo sapiens (human) | 0.003 | |
Pancreatic triacylglycerol lipase | Homo sapiens (human) | 0.3253 | |
Translocator protein | Rattus norvegicus (Norway rat) | 1 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.42 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.1903 | |
Fatty acid synthase | Homo sapiens (human) | 2.99 | |
Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 0.01 | |
Platelet-activating factor acetylhydrolase | Homo sapiens (human) | 0.05 | |
Diacylglycerol lipase-alpha | Mus musculus (house mouse) | 0.02 | |
Lysophosphatidylserine lipase ABHD12 | Homo sapiens (human) | 0.1682 | |
Diacylglycerol lipase-beta | Homo sapiens (human) | 0.24 | |
Monoacylglycerol lipase ABHD6 | Homo sapiens (human) | 0.03 | |
Acyl-protein thioesterase 2 | Rattus norvegicus (Norway rat) | 0.17 | |
Diacylglycerol lipase-alpha | Homo sapiens (human) | 0.2677 | |
Endothelial lipase | Homo sapiens (human) | 0.006 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, GZ; Woolley, CS | 1 |
Conde, K; Fabelo, C; Fischer, D; Goethel, J; Hur, J; Ingraham, HA; Krause, WC; Meza, C; Propst, R; Wagner, EJ | 1 |
2 other study(ies) available for sr 95531 and orlistat
Article | Year |
---|---|
Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluR-dependent mechanism.
Topics: Animals; Benzodioxoles; Benzoxazines; Biophysics; CA1 Region, Hippocampal; Cannabinoid Receptor Modulators; Castration; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Estradiol; Estrogens; Excitatory Amino Acid Agents; Female; GABA Antagonists; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Lactones; Male; Morpholines; NAD; Naphthalenes; Neural Inhibition; Neurons; Orlistat; Patch-Clamp Techniques; Phenols; Piperidines; Pyrazoles; Pyridazines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate | 2012 |
Testosterone Rapidly Augments Retrograde Endocannabinoid Signaling in Proopiomelanocortin Neurons to Suppress Glutamatergic Input from Steroidogenic Factor 1 Neurons via Upregulation of Diacylglycerol Lipase-α.
Topics: Action Potentials; Animals; Cerebral Cortex; Endocannabinoids; Energy Intake; Enzyme Inhibitors; Estradiol; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Female; GABA Antagonists; Glutamic Acid; Guinea Pigs; Lactones; Lipoprotein Lipase; Male; Neural Pathways; Neurons; Orlistat; Pro-Opiomelanocortin; Pyridazines; Signal Transduction; Steroidogenic Factor 1; Testosterone; Up-Regulation | 2017 |